| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Battaglia G, Yeh SY, O'He... |
3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine de... |
J Pharmacol Exp Ther |
1987 |
| Hekmatpanah CR, McKenna D... |
Reserpine does not prevent 3,4-methylenedioxymethamphetamine-induced n... |
Neurosci Lett |
1989 |
| Johnson MP, Nichols DE |
Neurotoxic effects of the alpha-ethyl homologue of MDMA following suba... |
Pharmacol Biochem Be... |
1989 |
| Hashimoto K, Goromaru T |
Reduction of in vivo binding of [3H]paroxetine in mouse brain by 3,4-m... |
Neuropharmacology |
1990 |
| Hekmatpanah CR, Peroutka ... |
5-hydroxytryptamine uptake blockers attenuate the 5-hydroxytryptamine-... |
Eur J Pharmacol |
1990 |
| Johnson MP, Huang XM, Obe... |
Behavioral, biochemical and neurotoxicological actions of the alpha-et... |
Eur J Pharmacol |
1990 |
| Nichols DE, Brewster WK, ... |
Nonneurotoxic tetralin and indan analogues of 3,4-(methylenedioxy)amph... |
J Med Chem |
1990 |
| Scheffel U, Ricaurte GA |
Paroxetine as an in vivo indicator of 3,4-methylenedioxymethamphetamin... |
Brain Res |
1990 |
| Winslow JT, Insel TR |
Serotonergic modulation of rat pup ultrasonic vocal development: studi... |
J Pharmacol Exp Ther |
1990 |
| McKenna DJ, Guan XM, Shul... |
3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential eff... |
Pharmacol Biochem Be... |
1991 |
| Johnson MP, Frescas SP, O... |
Synthesis and pharmacological examination of 1-(3-methoxy-4-methylphen... |
J Med Chem |
1991 |
| Battaglia G, Sharkey J, K... |
Neuroanatomic specificity and time course of alterations in rat brain ... |
Synapse |
1991 |
| Huang XM, Johnson MP, Nic... |
Reduction in brain serotonin markers by alpha-ethyltryptamine (Monase) |
Eur J Pharmacol |
1991 |
| Johnson MP, Frescas SP, O... |
Synthesis and pharmacological examination of 1-(3-methoxy-4-methylphen... |
J Med Chem |
1991 |
| Johnson MP, Huang XM, Nic... |
Serotonin neurotoxicity in rats after combined treatment with a dopami... |
Pharmacol Biochem Be... |
1991 |
| Millan MJ, Colpaert FC |
Methylenedioxymethamphetamine induces spontaneous tail-flicks in the r... |
Eur J Pharmacol |
1991 |
| Nash JF, Arora RC, Schrei... |
Effect of 3,4-methylenedioxymethamphetamine on [3H]paroxetine binding ... |
Biochem Pharmacol |
1991 |
| Sharkey J, McBean DE, Kel... |
Alterations in hippocampal function following repeated exposure to the... |
Psychopharmacology (... |
1991 |
| Hashimoto K, Maeda H, Gor... |
Antagonism of 3,4-methylenedioxymethamphetamine-induced neurotoxicity ... |
Eur J Pharmacol |
1992 |
| Lehmann J, DeSouza EB, Cu... |
Regional distribution to recovery of 5-HT levels after administration ... |
Ann N Y Acad Sci |
1992 |
| McCann UD, Ricaurte GA |
MDMA ('ecstasy') and panic disorder: induction by a single dose |
Biol Psychiatry |
1992 |
| Ricaurte GA, Martello AL,... |
Lasting effects of (+-)-3,4-methylenedioxymethamphetamine (MDMA) on ce... |
J Pharmacol Exp Ther |
1992 |
| Steele TD, Katz JL, Ricau... |
Evaluation of the neurotoxicity of N-methyl-1-(4-methoxyphenyl)-2-amin... |
Brain Res |
1992 |
| Hashimoto K, Maeda H, Hir... |
Drug effects on distribution of [3H]3,4-methylenedioxymethamphetamine ... |
Eur J Pharmacol |
1993 |
| Huang X, Nichols DE |
5-HT2 receptor-mediated potentiation of dopamine synthesis and central... |
Eur J Pharmacol |
1993 |
| Scanzello CR, Hatzidimitr... |
Serotonergic recovery after (+/-)3,4-(methylenedioxy) methamphetamine ... |
J Pharmacol Exp Ther |
1993 |
| Hewitt KE, Green AR |
Chlormethiazole, dizocilpine and haloperidol prevent the degeneration ... |
Neuropharmacology |
1994 |
| Marona-Lewicka D, Nichols... |
Behavioral effects of the highly selective serotonin releasing agent 5... |
Eur J Pharmacol |
1994 |
| Scheffel U, Dannals RF, S... |
Development of PET/SPECT ligands for the serotonin transporter |
NIDA Res Monogr |
1994 |
| Sprague JE, Huang X, Kant... |
Attenuation of 3,4-methylenedioxymethamphetamine (MDMA) induced neurot... |
Life Sci |
1994 |
| Skop BP, Finkelstein JA, ... |
The serotonin syndrome associated with paroxetine, an over-the-counter... |
Am J Emerg Med |
1994 |
| Aguirre N, Galbete JL, La... |
Methylenedioxymethamphetamine induces opposite changes in central pre-... |
Eur J Pharmacol |
1995 |
| Colado MI, Green AR |
The spin trap reagent alpha-phenyl-N-tert-butyl nitrone prevents 'ecst... |
Eur J Pharmacol |
1995 |
| Colado MI, Williams JL, G... |
The hyperthermic and neurotoxic effects of 'Ecstasy' (MDMA) and 3,4 me... |
Br J Pharmacol |
1995 |
| Sprague JE, Nichols DE |
The monoamine oxidase-B inhibitor L-deprenyl protects against 3,4-meth... |
J Pharmacol Exp Ther |
1995 |
| Sprague JE, Nichols DE |
Inhibition of MAO-B protects against MDMA-induced neurotoxicity in the... |
Psychopharmacology (... |
1995 |
| Sprague JE, Johnson MP, S... |
Studies on the mechanism of p-chloroamphetamine neurotoxicity |
Biochem Pharmacol |
1996 |
| Murray TK, Williams JL, M... |
The spin trap reagent PBN attenuates degeneration of 5-HT neurones in ... |
Neuropharmacology |
1996 |
| Bonson KR, Buckholtz JW, ... |
Chronic administration of serotonergic antidepressants attenuates the ... |
Neuropsychopharmacol... |
1996 |
| Colado MI, O'Shea E, Gran... |
In vivo evidence for free radical involvement in the degeneration of r... |
Br J Pharmacol |
1997 |
| Colado MI, Granados R, O'... |
Role of hyperthermia in the protective action of clomethiazole against... |
Br J Pharmacol |
1998 |
| Windhaber J, Maierhofer D... |
Panic disorder induced by large doses of 3,4-methylenedioxymethampheta... |
J Clin Psychopharmac... |
1998 |
| Aguirre N, Barrionuevo M,... |
The role of dopaminergic systems in the perinatal sensitivity to 3, 4-... |
J Pharmacol Exp Ther |
1998 |
| O'Shea E, Granados R, Est... |
The relationship between the degree of neurodegeneration of rat brain ... |
Neuropharmacology |
1998 |
| Obradovic T, Imel KM, Whi... |
Repeated exposure to methylenedioxymethamphetamine (MDMA) alters nucle... |
Brain Res |
1998 |
| Obradovic T, Imel KM, Whi... |
Repeated exposure to methylenedioxymethamphetamine (MDMA) alters nucle... |
Brain Res |
1998 |
| Yeh SY |
N-tert-butyl-alpha-phenylnitrone protects against 3,4-methylenedioxyme... |
Synapse |
1999 |
| Yeh SY, Dersch C, Rothman... |
Effects of antihistamines on 3, 4-methylenedioxymethamphetamine-induce... |
Synapse |
1999 |
| Colado MI, Granados R, O'... |
The acute effect in rats of 3,4-methylenedioxyethamphetamine (MDEA, 'e... |
Pharmacol Toxicol |
1999 |
| Colado MI, Esteban B, O'S... |
Studies on the neuroprotective effect of pentobarbitone on MDMA-induce... |
Psychopharmacology (... |
1999 |
| Mortensen OV, Kristensen ... |
Molecular cloning, expression and characterization of a bovine seroton... |
Brain Res Mol Brain ... |
1999 |
| Aguirre N, Barrionuevo M,... |
Alpha-lipoic acid prevents 3,4-methylenedioxy-methamphetamine (MDMA)-i... |
Neuroreport |
1999 |
| Edwards JG, Anderson I |
Systematic review and guide to selection of selective serotonin reupta... |
Drugs |
1999 |
| Russell BR, Laverty R |
Correlation between 5-HT content and uptake site density following (S)... |
Ann N Y Acad Sci |
2000 |
| Shirayama Y, Hashimoto K,... |
3,4-Methylenedioxymethamphetamine (MDMA, ecstasy)-induced egr-1 mRNA i... |
Eur J Pharmacol |
2000 |
| Sanchez V, Camarero J, Es... |
The mechanisms involved in the long-lasting neuroprotective effect of ... |
Br J Pharmacol |
2001 |
| Colado MI, O'Shea E, Este... |
Studies on the neuroprotective effect of the enantiomers of AR-A008055... |
Psychopharmacology (... |
2001 |
| Connor TJ, Dennedy MC, Ha... |
Methylenedioxymethamphetamine-induced suppression of interleukin-1beta... |
Eur J Pharmacol |
2001 |
| Mamamoorthy Y, Tyndale R,... |
Cytochrome P450 2D6.1 and cytochrome P450 2D6.10 differ in catalytic a... |
Pharmacogenetics |
2001 |
| O'Loinsigh ED, Boland G, ... |
Behavioural, hyperthermic and neurotoxic effects of 3,4- methylenediox... |
Prog Neuropsychophar... |
2001 |
| Mortensen OV, Kristensen ... |
Species-scanning mutagenesis of the serotonin transporter reveals resi... |
J Neurochem |
2001 |
| Ramamoorthy Y, Tyndale RF... |
Cytochrome P450 2D6.1 and cytochrome P450 2D6.10 differ in catalytic a... |
Pharmacogenetics |
2001 |
| Farré M, Roset PN, de la ... |
Interaction of Paroxetine and MDMA in humans |
College on Problems... |
2002 |
| Fone KF, Beckett SG, Toph... |
Long-term changes in social interaction and reward following repeated ... |
Psychopharmacology (... |
2002 |
| Szabo Z, McCann UD, Wilso... |
Comparison of (+)-(11)C-McN5652 and (11)C-DASB as Serotonin Transporte... |
J Nucl Med |
2002 |
| O'Shea E, Easton N, Fry J... |
Protection against 3,4-methylenedioxymethamphetamine-induced neurodege... |
J Neurochem |
2002 |
| Ramamoorthy Y, Yu A, Suh ... |
Reduced (+/-)-3,4-methylenedioxymethamphetamine ('Ecstasy') metabolism... |
Biochem Pharmacol |
2002 |
| Fernandez F, Aguerre S, M... |
Influences of the corticotropic axis and sympathetic activity on neuro... |
Eur J Neurosci |
2002 |
| Sanchez V, Camarero J, O\... |
Differential effect of dietary selenium on the long-term neurotoxicity... |
Neuropharmacology |
2003 |
| Bull EJ, Hutson PH, Fone ... |
Reduced social interaction following 3,4-methylenedioxymethamphetamine... |
Neuropharmacology |
2003 |
| Bogen IL, Haug KH, Myhre ... |
Short- and long-term effects of MDMA ("ecstasy") on synaptosomal and v... |
Neurochem Int |
2003 |
| Wang JS, DeVane CL |
Involvement of CYP3A4, CYP2C8, and CYP2D6 in the metabolism of (R)- an... |
Drug Metab Dispos |
2003 |
| Pacifici R, Pichini S, Zu... |
Paroxetine Inhibits Acute Effects of MDMA on the Immune System in Huma... |
J Pharmacol Exp Ther |
2004 |
| Schruers K, Griez E |
The effects of tianeptine or paroxetine on 35 CO2 provoked panic in pa... |
J Psychopharmacol |
2004 |
| Segura M, Farre M, Pichin... |
Contribution of cytochrome P450 2D6 to 3,4-methylenedioxymethamphetami... |
Clin Pharmacokinet |
2005 |
| Chipana C, Camarasa J, Pu... |
Memantine prevents MDMA-induced neurotoxicity |
Neurotoxicology |
2008 |
| Izzo AA, Ernst E |
Interactions between herbal medicines and prescribed drugs: an updated... |
Drugs |
2009 |
| Martínez-Clemente J, Escu... |
Interaction of mephedrone with dopamine and serotonin targets in rats |
Eur Neuropsychopharm... |
2011 |
| Schoenfuss HL, Furlong ET... |
Complex mixtures, complex responses: Assessing pharmaceutical mixtures... |
Environ Toxicol Chem |
2015 |
| Mitchell-Mata C, Thomas B... |
Two Fatal Intoxications Involving 3-Methoxyphencyclidine |
J Anal Toxicol |
2017 |
